SCHEMBL6558235

SCHEMBL6558235

Cc1cc2cccc3c2n1[C@H](CN1CCOCC1)[C]O3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.39
CNR2 P34972 6/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.39
MTOR P42345 1/20 0.39
RAB9A P51151 1/20 0.39
RGS12 O14924 1/20 0.36
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8069945 0.79 CNR1 (0.56) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL4089479 0.69 CNR1 (0.52) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL31318122 0.69 CNR1 (0.52) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL3176889 0.69 CNR1 (0.52) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL9700209 0.68 CNR1 (0.46) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL7024508 0.67 CNR1 (0.42) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL5792357 0.66 CNR1 (0.55) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL31318123 0.66 CNR1 (0.55) CNR1CNR2CYP3A4CYP2C9MEN1
SCHEMBL8075187 0.64 LMNA (0.46) CNR1CNR2MEN1KMT2AMAPT
SCHEMBL8061084 0.63 LMNA (0.44) CNR1CNR2ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490111-A2 EDG-RECEPTOR AGONISTS FOR THE TREATMENT OF HYPERTENSION Solvay Pharmaceuticals GmbH (DE) 2004-12-29 EP disclosed
WO-2003051395-A2 EDG-RECEPTOR AGONIST FOR THE TREATMENT OF HYPERTENSION SOLVAY PHARMACEUTICALS GMBH (DE) 2003-06-26 WO disclosed